News | Proton Therapy | December 19, 2017

Baptist Hospital's Miami Cancer Institute Treats First Patient With Proteus Plus Proton Therapy

First applications for advanced proton therapy system are children with cancer

Baptist Hospital's Miami Cancer Institute Treats First Patient With Proteus Plus Proton Therapy

December 19, 2017 — IBA (Ion Beam Applications SA) announced that Miami Cancer Institute treated its first patients, children with cancer, on IBA’s Proteus Plus proton therapy system.

Miami Cancer Institute is equipped with a comprehensive suite of advanced radiotherapy equipment highlighted by Proteus Plus, which is equipped with a three-gantry, beam matched configuration using the latest in proton therapy including pencil beam scanning, cone beam computed tomography (CBCT) image guidance, robotic patient table and enhanced workflow. The proton therapy center will be the first in South Florida with extensive reach to the Caribbean, Latin America and beyond.

The $430 million Institute also provides a wide array of advanced radiation therapy treatment options including Gamma Knife radiosurgery, CyberKnife stereotactic radiation therapy, tomotherapy and volumetric modulated arc therapy (VMAT), brachytherapy, magnetic resonance imaging (MRI)-guided linear accelerator (linac) radiation therapy, GRID therapy and radioisotope therapy.

“This is the most cutting-edge proton therapy technology available,” said Minesh Mehta, M.D., deputy director of the Miami Cancer Institute and chief of radiation oncology. “It uses a volumetrically image-guided pencil-beam approach with on-board surface-monitoring systems with beam-gating capability, allowing us to target more complicated tumors and, for most situations, further decreases radiation exposure to normal tissues in comparison to older proton techniques. That means that there is significantly less damage to healthy tissue, a decrease in side effects and less chance of a recurrence of cancer due to radiation exposure.”

For more information: www.iba-worldwide.com

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Overlay Init